These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 38020342)

  • 1. Management of comorbidities in difficult and severe asthma.
    Khan J; Moran B; McCarthy C; Butler MW; Franciosi AN
    Breathe (Sheff); 2023 Sep; 19(3):230133. PubMed ID: 38020342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do not forget asthma comorbidities in pediatric severe asthma!
    Ronco L; Folino A; Goia M; Crida B; Esposito I; Bignamini E
    Front Pediatr; 2022; 10():932366. PubMed ID: 35967579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidities associated with severe asthma.
    Patel GB; Peters AT
    J Precis Respir Med; 2019 Dec; 2(1):5-9. PubMed ID: 33615229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences.
    Bakakos A; Rovina N; Loukides S; Bakakos P
    Expert Opin Biol Ther; 2022 Jul; 22(7):855-870. PubMed ID: 35712995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Li A; Chang AB
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    von Bülow A; Backer V; Bodtger U; Søes-Petersen NU; Vest S; Steffensen I; Porsbjerg C
    Respir Med; 2018 Dec; 145():41-47. PubMed ID: 30509715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Comorbidities in Difficult-to-Control Asthma in Adults and Children.
    Gaffin JM; Castro M; Bacharier LB; Fuhlbrigge AL
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):397-408. PubMed ID: 34863928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
    Petsky HL; Kynaston JA; Turner C; Li AM; Cates CJ; Lasserson TJ; Chang AB
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005603. PubMed ID: 17443604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe asthma in children: Evaluation and management.
    Haktanir Abul M; Phipatanakul W
    Allergol Int; 2019 Apr; 68(2):150-157. PubMed ID: 30648539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid "treatable traits" in difficult asthma: Current evidence and clinical evaluation.
    Tay TR; Hew M
    Allergy; 2018 Jul; 73(7):1369-1382. PubMed ID: 29178130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difficult to Treat and Severe Asthma: Management Strategies.
    Narasimhan K
    Am Fam Physician; 2021 Mar; 103(5):286-290. PubMed ID: 33630543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional exhaled nitric oxide and asthma treatment adherence.
    Butler CA; Heaney LG
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):59-64. PubMed ID: 33369570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab.
    Menzies-Gow A; Hoyte FL; Price DB; Cohen D; Barker P; Kreindler J; Jison M; Brooks CL; Papeleu P; Katial R
    Adv Ther; 2022 May; 39(5):2065-2084. PubMed ID: 35287231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV
    Pérez de Llano L; Dávila I; Martínez-Moragón E; Domínguez-Ortega J; Almonacid C; Colás C; García-Rivero JL; Carmona L; García de Yébenes MJ; Cosío BG;
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2725-2731. PubMed ID: 33549843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
    McDowell PJ; Diver S; Yang F; Borg C; Busby J; Brown V; Shrimanker R; Cox C; Brightling CE; Chaudhuri R; Pavord ID; Heaney LG;
    Lancet Respir Med; 2021 Oct; 9(10):1174-1184. PubMed ID: 33971168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic approach to difficult-to-treat asthma and severe asthma].
    Venancio-Hernández M; Mendieta-Flores E; Mendiola-Marín J; Alaniz-Flores AK; Reyes-Arellano M
    Rev Alerg Mex; 2022; 69 Suppl 1():s94-s111. PubMed ID: 34998314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difficult-to-treat and severe asthma in general practice: delivery and evaluation of an educational program.
    Hains I; Meyers J; Sterling K; Yoo J; Reddel H; Weston C
    BMC Fam Pract; 2019 Jul; 20(1):99. PubMed ID: 31301742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe asthma in children.
    Guilbert TW; Bacharier LB; Fitzpatrick AM
    J Allergy Clin Immunol Pract; 2014; 2(5):489-500. PubMed ID: 25213041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
    Anderson WC; Banzon TM; Chawes B; Papadopoulos NG; Phipatanakul W; Szefler SJ
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):693-701. PubMed ID: 36646381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II.
    Chipps BE; Haselkorn T; Paknis B; Ortiz B; Bleecker ER; Kianifard F; Foreman AJ; Szefler SJ; Zeiger RS;
    J Allergy Clin Immunol; 2018 May; 141(5):1590-1597.e9. PubMed ID: 28797732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.